Type:
Educational Exhibit
Keywords:
Neoplasia, Multidisciplinary cancer care, Surgery, Structured reporting, CT, Kidney, Genital / Reproductive system male
Authors:
F. Rosa1, I. Verardo1, S. Barbagallo1, G. Perugin1, C. Martinetti2, L. Basso1, L. Secondini1, S. Sanguinetti1, C. E. Neumaier1; 1Genova/IT, 2Genoa/IT
DOI:
10.26044/ecr2019/C-1015
References
1. Crispen,
P.
L.
et al. Lymphnode dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates.
Eur Urol 2011; 59,
18–23
2. Ljungberg,
B.
et al.
EAU guidelines on renal cell carcinoma: 2014 update.
Eur Urol 2015; 67,
913–924
3. MacLennan,
S.
et al.
Systematic review of oncological outcomes following surgical management of localised renal cancer.
Eur Urol 2012; 61,
972–993,
4. Simmons MN,
Ching CB,
Samplaski MK,
et al.
Kidney tumor location measurement using the C index method.
J Urol 2010; 183:1708–1713
5. Kutikov A,
Uzzo RG.
The R.E.N.A.L.
nephrometry score: a comprehensive standardized system for quantitating renal tumor size,
location and depth.
J Urol 2009; 182:844–853
6. Ficarra V,
Novara G,
Secco S,
et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery.
Eur Urol 2009; 56:786–793
7. Campbell SC,
Novick AC,
Belldegrun A et al.
Guideline for management of the clinical T1 renal mass.
J Urol 2009; 182:1271–1279
8. Karellas ME,
O’Brien MF,
Jang TL et al.
Partial nephrectomy for selected renal cortical tumours of ≥ 7 cm.
BJU Int 2010; 106:1484–1487
9. Shah PH,
Lyon TD,
Lohse CM et al.
Prognostic evaluation of perinephric fat,
renal sinus fat,
and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma. BJU Int.
2018 Aug 16.
doi: 10.1111/bju.14523
10.
Oh JJ,
Lee JK,
Do Song B et al. Accurate Risk Assessment of Patients with Pathologic T3aN0M0 Renal Cell Carcinoma.
Sci Rep.
2018 Sep 17;8(1):13914.
doi: 10.1038/s41598-018-32362-w
11.Guzzo TJ,
Pierorazio PM,
Schaeffer EM et al.
The accuracy of multidetector computerized tomography for evaluating tumor thrombus in patients with renal cell carcinoma.
J Urol 2009; 181:486–490,
12.Karnes RJ,
Blute ML.
Surgery insight: management of renal cell carcinoma with associated inferior vena cava thrombus.
Nat Clin Pract Urol 2008; 5:329–339
13.Tadayoni A,
Paschall AK,
Malayeri AA.
Assessing lymph node status in patients with kidney cancer.
Transl Androl Urol.
2018 Oct;7(5):766-773.doi: 10.21037/tau.2018.07.19.
Review.
PubMed PMID: 30456180
14.Studer UE,
Scherz S,
Scheidegger J et al.
Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 1990; 144:243–245
15.Campi R,
Minervini A,
Mari A et al.
Anatomical templates of lymph node dissection for upper tract urothelial carcinoma: a systematic review of the literature.
Expert Rev Anticancer Ther.
2017 Mar;17(3):235-246.
doi: 10.1080/14737140.2017.1285232.
16.O’Malley RL,
Godoy G,
Kanofsky JA,
Taneja SS. The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review.
J Urol 2009; 181:2009–2017
17.Margulis V,
Sánchez-Ortiz RF,
Tamboli P et al.
Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management. Cancer 2007; 109:2025–2030
18.Karellas ME,
Jang TL,
Kagiwada MA et al.
Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection.
BJU Int 2009; 103:160–16
19.Borregales LD,
Adibi M,
Thomas AZ,
et al.
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma.
Ther Adv Urol.
2016 Apr;8(2):130-41.
doi: 10.1177/1756287215612962
20.Shinagare AB,
Krajewski KM,
Braschi-Amirfarzan M et al.
Advanced Renal Cell Carcinoma: Role of the Radiologist in the Era of Precision Medicine.
Radiology.2017Aug;284(2):333-351.
doi: 10.1148/radiol.2017160343